Overview Dividends

(UROY) Uranium Royalty - Ratings and Ratios

Exchange: NASDAQ • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA91702V1013

Royalties, Physical Uranium

UROY EPS (Earnings per Share)

EPS (Earnings per Share) of UROY over the last years for every Quarter: "2020-10": -0.0001, "2021-01": -0.0039, "2021-04": -0.0105, "2021-07": -0.0056, "2021-10": -0.0055, "2022-01": -0.0171, "2022-04": -0.005, "2022-07": -0.0198, "2022-10": -0.0175, "2023-01": -0.0135, "2023-04": 0.0049, "2023-07": -0.0078, "2023-10": 0.0224, "2024-01": 0.0216, "2024-04": 0.0341, "2024-07": -0.013, "2024-10": -0.0026, "2025-01": -0.01, "2025-04": -0.01, "2025-07": 0.01, "2025-10": 0,
EPS Growth (3Y CAGR): 164.43%
EPS Trend (3Y Correlation): -8.2%

UROY Revenue

Revenue of UROY over the last years for every Quarter: 2020-10: 0, 2021-01: 0, 2021-04: 0, 2021-07: 0, 2021-10: 0, 2022-01: 0, 2022-04: 0, 2022-07: 0, 2022-10: 0, 2023-01: 0, 2023-04: 13.854, 2023-07: 15.318, 2023-10: 15.318, 2024-01: 15.16, 2024-04: 12.228, 2024-07: 0, 2024-10: 10.903, 2025-01: 0.004, 2025-04: 4.688, 2025-07: 33.212, 2025-10: null,
Revenue Growth (3Y CAGR): 243.27%
Revenue Trend (3Y Correlation): 23.3%
Risk via 10d forecast
Volatility 74.9%
Value at Risk 5%th 108%
Relative Tail Risk -12.21%
Reward TTM
Sharpe Ratio 0.75
Alpha 22.45
Character TTM
Hurst Exponent 0.356
Beta 1.213
Beta Downside 1.201
Drawdowns 3y
Max DD 59.73%
Mean DD 26.71%
Median DD 28.77%

Description: UROY Uranium Royalty October 27, 2025

Uranium Royalty Corp. (NASDAQ:UROY) is a Vancouver-based pure-play royalty firm that acquires, holds, and monetises uranium-related royalties and physical uranium assets across Canada, the United States, Namibia, and Spain. Since its 2017 incorporation, the company has built a geographically diversified portfolio that includes both royalty interests in operating mines and direct holdings of uranium concentrate.

Key metrics that investors watch include the company’s royalty income, which averaged ≈ $7 million in 2023, and its cash position of roughly $30 million, providing liquidity to pursue new royalty deals. The uranium sector is currently driven by rising spot prices (≈ $55 lb-U in Q3 2024, up ~30% YoY) and renewed policy support for nuclear power in the U.S. and Europe, which together underpin a projected 2–3% annual growth in global uranium demand through 2030. UROY’s exposure to high-grade assets in Namibia-a region that supplies ~10% of world uranium-offers a potential upside if supply constraints tighten.

For a deeper quantitative comparison of UROY’s royalty yields against peers, the ValueRay platform offers a concise dashboard of key metrics.

UROY Stock Overview

Market Cap in USD 482m
Sub-Industry Coal & Consumable Fuels
IPO / Inception 2021-04-28
Return 12m vs S&P 500 29.4%
Analyst Rating 4.20 of 5

UROY Dividends

Currently no dividends paid

UROY Growth Ratios

CAGR 3y 11.32%
CAGR/Max DD Calmar Ratio 0.19
CAGR/Mean DD Pain Ratio 0.42
Current Volume 1895.6k
Average Volume 5254.4k

Piotroski VR‑10 (Strict, 0-10) 2.0

Net Income (-1.97m TTM) > 0 and > 6% of Revenue (6% = 2.93m TTM)
FCFTA 0.05 (>2.0%) and ΔFCFTA 48.65pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 488.2% (prev 519.9%; Δ -31.70pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.07 (>3.0%) and CFO 21.9m > Net Income -1.97m (YES >=105%, WARN >=100%)
NO Net Debt/EBITDA fails (EBITDA <= 0)
Current Ratio 201.7 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (133.7m) change vs 12m ago 10.64% (target <= -2.0% for YES)
Gross Margin 17.12% (prev 31.01%; Δ -13.89pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 17.00% (prev 15.48%; Δ 1.52pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio -14.54 (EBITDA TTM -1.63m / Interest Expense TTM 123.0k) >= 6 (WARN >= 3)

ValueRay F-Score (Strict, 0-100) 44.38

1. Piotroski 2.0pt = -3.0
2. FCF Yield 2.33% = 1.16
3. FCF Margin 29.93% = 7.48
4. Debt/Equity 0.00 = 2.50
5. Debt/Ebitda 5.40 = -2.50
6. ROIC - WACC (= -14.62)% = -12.50
7. RoE -0.67% = -0.11
8. Rev. Trend 23.34% = 1.75
9. EPS Trend -8.17% = -0.41

What is the price of UROY shares?

As of November 14, 2025, the stock is trading at USD 3.70 with a total of 1,895,645 shares traded.
Over the past week, the price has changed by +3.06%, over one month by -13.15%, over three months by +42.31% and over the past year by +47.41%.

Is Uranium Royalty a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Uranium Royalty (NASDAQ:UROY) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 44.38 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UROY is around 3.31 USD . This means that UROY is currently overvalued and has a potential downside of -10.54%.

Is UROY a buy, sell or hold?

Uranium Royalty has received a consensus analysts rating of 4.20. Therefore, it is recommended to buy UROY.
  • Strong Buy: 2
  • Buy: 2
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the UROY price?

Issuer Target Up/Down from current
Wallstreet Target Price 4.4 18.6%
Analysts Target Price 4.4 18.6%
ValueRay Target Price 3.9 4.6%

UROY Fundamental Data Overview November 08, 2025

Market Cap CAD = 676.4m (482.0m USD * 1.4032 USD.CAD)
P/E Forward = 588.2353
P/S = 9.876
P/B = 2.6317
Beta = 2.167
Revenue TTM = 48.8m CAD
EBIT TTM = -1.79m CAD
EBITDA TTM = -1.63m CAD
Long Term Debt = 196.0k CAD (from capitalLeaseObligations, last quarter)
Short Term Debt = 57.0k CAD (from shortTermDebt, last quarter)
Debt = 196.0k CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = -8.78m CAD (from netDebt column, last quarter)
Enterprise Value = 627.5m CAD (676.4m + Debt 196.0k - CCE 49.1m)
Interest Coverage Ratio = -14.54 (Ebit TTM -1.79m / Interest Expense TTM 123.0k)
FCF Yield = 2.33% (FCF TTM 14.6m / Enterprise Value 627.5m)
FCF Margin = 29.93% (FCF TTM 14.6m / Revenue TTM 48.8m)
Net Margin = -4.04% (Net Income TTM -1.97m / Revenue TTM 48.8m)
Gross Margin = 17.12% ((Revenue TTM 48.8m - Cost of Revenue TTM 40.5m) / Revenue TTM)
Gross Margin QoQ = 15.97% (prev 3.80%)
Tobins Q-Ratio = 2.10 (Enterprise Value 627.5m / Total Assets 298.3m)
Interest Expense / Debt = 2.04% (Interest Expense 4000 / Debt 196.0k)
Taxrate = -4.02% (negative due to tax credits) (-59.0k / 1.47m)
NOPAT = -1.86m (EBIT -1.79m * (1 - -4.02%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 201.7 (out of range, set to none) (Total Current Assets 239.5m / Total Current Liabilities 1.19m)
Debt / Equity = 0.00 (Debt 196.0k / totalStockholderEquity, last quarter 297.0m)
Debt / EBITDA = 5.40 (negative EBITDA) (Net Debt -8.78m / EBITDA -1.63m)
Debt / FCF = -0.60 (Net Debt -8.78m / FCF TTM 14.6m)
Total Stockholder Equity = 292.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.66% (Net Income -1.97m / Total Assets 298.3m)
RoE = -0.67% (Net Income TTM -1.97m / Total Stockholder Equity 292.4m)
RoCE = -0.61% (EBIT -1.79m / Capital Employed (Equity 292.4m + L.T.Debt 196.0k))
RoIC = -0.63% (negative operating profit) (NOPAT -1.86m / Invested Capital 297.2m)
WACC = 14.00% (E(676.4m)/V(676.6m) * Re(14.0%) + D(196.0k)/V(676.6m) * Rd(2.04%) * (1-Tc(-0.04)))
Discount Rate = 14.0% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 10.30%
[DCF Debug] Terminal Value 48.77% ; FCFE base≈14.6m ; Y1≈9.59m ; Y5≈4.39m
Fair Price DCF = 0.33 (DCF Value 43.7m / Shares Outstanding 133.6m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -8.17 | EPS CAGR: 164.4% | SUE: 0.84 | # QB: 0
Revenue Correlation: 23.34 | Revenue CAGR: 243.3% | SUE: N/A | # QB: 0

Additional Sources for UROY Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle